BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23931957)

  • 1. Examining the construction and representation of drugs as a policy problem in Australia's National Drug Strategy documents 1985-2010.
    Lancaster K; Ritter A
    Int J Drug Policy; 2014 Jan; 25(1):81-7. PubMed ID: 23931957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Producing the 'problem of drugs': A cross national-comparison of 'recovery' discourse in two Australian and British reports.
    Lancaster K; Duke K; Ritter A
    Int J Drug Policy; 2015 Jul; 26(7):617-25. PubMed ID: 25962733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Producing alcohol and other drugs as a policy 'problem': A critical analysis of South Africa's 'National Drug Master Plan' (2013-2017).
    Pienaar K; Savic M
    Int J Drug Policy; 2016 Apr; 30():35-42. PubMed ID: 26806640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Problematisation and centralised assessment in drug treatment sector reform.
    Berends L
    Int J Drug Policy; 2020 Jun; 80():102561. PubMed ID: 31611166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1985 and all that: the establishment of Australia's Drug Strategy.
    Blewett N
    Drug Alcohol Rev; 2009 Mar; 28(2):96-8. PubMed ID: 19320691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Governing through problems: the formulation of policy on amphetamine-type stimulants (ATS) in Australia.
    Fraser S; Moore D
    Int J Drug Policy; 2011 Nov; 22(6):498-506. PubMed ID: 22054738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Potential issues of morbidity, toxicity and dependence': Problematizing the up-scheduling of over-the-counter codeine in Australia.
    Weier M; Farrugia A
    Int J Drug Policy; 2020 Jun; 80():102538. PubMed ID: 31362859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social construction and the evidence-based drug policy endeavour.
    Lancaster K
    Int J Drug Policy; 2014 Sep; 25(5):948-51. PubMed ID: 24491356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sameness and difference: metaphor and politics in the constitution of addiction, social exclusion and gender in Australian and Swedish drug policy.
    Moore D; Fraser S; Törrönen J; Tinghög ME
    Int J Drug Policy; 2015 Apr; 26(4):420-8. PubMed ID: 25662895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Producing the 'problem' of new psychoactive substances (NPS) in English prisons.
    Duke K
    Int J Drug Policy; 2020 Jun; 80():102479. PubMed ID: 31155432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laws prohibiting peer distribution of injecting equipment in Australia: A critical analysis of their effects.
    Lancaster K; Seear K; Treloar C
    Int J Drug Policy; 2015 Dec; 26(12):1198-206. PubMed ID: 26118796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "What's the problem?": Australian public policy constructions of domestic and family violence.
    Murray S; Powell A
    Violence Against Women; 2009 May; 15(5):532-52. PubMed ID: 19208919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The print media's construction of the 'drug problem' in Victorian newspapers: The case of North Richmond Community Health's medically supervised injecting room.
    Whiteside B; Dunn M
    Drug Alcohol Rev; 2022 May; 41(4):818-829. PubMed ID: 34674323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol policy and harm reduction in Australia.
    Loxley W; Gray D; Wilkinson C; Chikritzhs T; Midford R; Moore D
    Drug Alcohol Rev; 2005 Nov; 24(6):559-68. PubMed ID: 16361215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum to "Examining the construction and representation of drugs as a policy problem in Australia's National Drug Strategy documents 1985-2010" [Int. J. Drug Policy 25 (2014) 81-87].
    Lancaster K; Ritter A
    Int J Drug Policy; 2016 May; 31():205. PubMed ID: 27207210
    [No Abstract]   [Full Text] [Related]  

  • 16. What's the low back pain problem represented to be? An analysis of discourse of the Australian policy directives.
    Costa N; Blyth FM; Parambath S; Huckel Schneider C
    Disabil Rehabil; 2023 Oct; 45(20):3312-3322. PubMed ID: 36150033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'It's good being part of the community and doing the right thing': (Re)problematising 'community' in new recovery-oriented policy and consumer accounts.
    Fomiatti R
    Int J Drug Policy; 2020 Jun; 80():102450. PubMed ID: 31229446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Legislating thresholds for drug trafficking: a policy development case study from New South Wales, Australia.
    Hughes CE; Ritter A; Cowdery N
    Int J Drug Policy; 2014 Sep; 25(5):992-1000. PubMed ID: 24735952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges to pharmaceutical policymaking: lessons from Australia's national medicines policy.
    Lipworth W; Doran E; Kerridge I; Day R
    Aust Health Rev; 2014 May; 38(2):160-8. PubMed ID: 24589424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From scrubland to vintage wine: Australia's response to substance-related problems in the last 40 years.
    Rankin JG
    Drug Alcohol Rev; 2003 Sep; 22(3):255-62. PubMed ID: 15385219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.